447 related articles for article (PubMed ID: 12866567)
1. Radical surgery does not recover immunodeficiency associated with gastric cancer.
Romano F; Caprotti R; Bravo AF; Conti M; Colombo G; Piacentini G; Uggeri F; Uggeri F
J Exp Clin Cancer Res; 2003 Jun; 22(2):179-83. PubMed ID: 12866567
[TBL] [Abstract][Full Text] [Related]
2. Biological, histological, and clinical impact of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Cesana G; Berselli M; Gaia Piacentini M; Caprotti R; Bovo G; Uggeri F
J Surg Oncol; 2004 Dec; 88(4):240-7. PubMed ID: 15565596
[TBL] [Abstract][Full Text] [Related]
3. Immunodeficiency in different histotypes of radically operable gastrointestinal cancers.
Romano F; Uggeri F; Crippa S; Di Stefano G; Scotti M; Scaini A; Caprotti R; Uggeri F
J Exp Clin Cancer Res; 2004 Jun; 23(2):195-200. PubMed ID: 15354402
[TBL] [Abstract][Full Text] [Related]
4. Phase-II randomized study of preoperative IL-2 administration in radically operable gastric cancer patients.
Romano F; Piacentini MG; Franciosi C; Caprotti R; De Fina S; Cesana G; Uggeri F; Conti M; Uggeri F
Hepatogastroenterology; 2004; 51(60):1872-6. PubMed ID: 15532847
[TBL] [Abstract][Full Text] [Related]
5. IGF-1 and IGF-1BP3 in gastric adenocarcinoma. Preliminary study.
Franciosi CM; Piacentini MG; Conti M; Romano F; Musco F; Caprotti R; Rovelli F; Uggeri F
Hepatogastroenterology; 2003; 50(49):297-300. PubMed ID: 12630045
[TBL] [Abstract][Full Text] [Related]
6. Preoperative IL-2 immunotherapy enhances tumor infiltrating lymphocytes (TILs) in gastric cancer patients.
Romano F; Cesana G; Caprotti R; Bovo G; Uggeri F; Piacentini MG; Crippa S; Uggeri F
Hepatogastroenterology; 2006; 53(70):634-8. PubMed ID: 16995478
[TBL] [Abstract][Full Text] [Related]
7. Low-dose interleukin-2 administered pre-operatively to patients with gastric cancer activates peripheral and peritumoral lymphocytes but does not affect prognosis.
Cesana GC; Romano F; Piacentini G; Scotti M; Brenna A; Bovo G; Vaghi M; Aletti G; Caprotti R; Kaufman H; Uggeri F
Ann Surg Oncol; 2007 Apr; 14(4):1295-304. PubMed ID: 17225981
[TBL] [Abstract][Full Text] [Related]
8. [Radical surgical treatment of gastric cancer. Personal experience].
Meriggi F; Forni E
G Chir; 2002 Oct; 23(10):361-7. PubMed ID: 12611256
[TBL] [Abstract][Full Text] [Related]
9. Alteration of hypothalamus-pituitary-adrenal glands axis in colorectal cancer patients.
Mussi C; Angelini C; Crippa S; Caprotti R; Fumagalli L; Motta V; Uggeri F
Hepatogastroenterology; 2003 Dec; 50 Suppl 2():ccxxviii-ccxxxi. PubMed ID: 15244187
[TBL] [Abstract][Full Text] [Related]
10. Alteration of hypothalamus-pituitary-adrenal gland axis in colorectal cancer patients. Preliminary report.
Crippa S; Mussi C; Angelini C; Caprotti R; Bonardi C; Muselli P; Scotti M; Piacentini G; Uggeri F
Minerva Chir; 2003 Aug; 58(4):581-5. PubMed ID: 14603172
[TBL] [Abstract][Full Text] [Related]
11. Effect of bariatric surgery on peripheral blood lymphocyte subsets in women.
Merhi ZO; Durkin HG; Feldman J; Macura J; Rodriguez C; Minkoff H
Surg Obes Relat Dis; 2009; 5(2):165-71. PubMed ID: 18996763
[TBL] [Abstract][Full Text] [Related]
12. Search for immunomodulatory effects of blood transfusion in gastric cancer patients: flow cytometry of Th1/Th2 cells in peripheral blood.
Sun CF; Hsieh YY; Ngan KW; Wang WT
Ann Clin Lab Sci; 2001 Apr; 31(2):171-8. PubMed ID: 11337907
[TBL] [Abstract][Full Text] [Related]
13. [The role of superextended lymphadenectomy (D4) in gastric cancer].
Pugliese R; Maggioni D; Sansonna F; Scandroglio I; Di Lernia S; Boniardi M; Bramerio MA
Minerva Chir; 2004 Aug; 59(4):325-35. PubMed ID: 15278027
[TBL] [Abstract][Full Text] [Related]
14. Minimally invasive versus open Roux-en-Y gastric bypass: effect on immune effector cells.
Whitson BA; D'Cunha J; Hoang CD; Wu B; Ikramuddin S; Buchwald H; Panoskaltsis-Mortari A; Kratzke RA; Miller JS; Maddaus MA
Surg Obes Relat Dis; 2009; 5(2):181-93. PubMed ID: 18996756
[TBL] [Abstract][Full Text] [Related]
15. Phase IB study on prevention of surgery-induced immunodeficiency with preoperative administration of low-dose subcutaneous interleukin-2 in gastric cancer patients.
Cerea K; Romano F; Bravo AF; Motta V; Uggeri F; Brivio F; Fumagalli LA; Uggeri F
J Surg Oncol; 2001 Sep; 78(1):32-7. PubMed ID: 11519066
[TBL] [Abstract][Full Text] [Related]
16. Hyporesponsiveness of T cell subsets after cardiac surgery: a product of altered cell function or merely a result of absolute cell count changes in peripheral blood?
Franke A; Lante W; Kurig E; Zöller LG; Weinhold C; Markewitz A
Eur J Cardiothorac Surg; 2006 Jul; 30(1):64-71. PubMed ID: 16730447
[TBL] [Abstract][Full Text] [Related]
17. Characterization of immune responses in gastric cancer patients: a possible impact of H. pylori to polarize a tumor-specific type 1 response?
van den Engel NK; Winter H; Rüttinger D; Shau I; Schiller M; Mayer B; Moudgil T; Meimarakis G; Stolte M; Jauch KW; Fox BA; Hatz RA
Clin Immunol; 2006 Sep; 120(3):285-96. PubMed ID: 16765089
[TBL] [Abstract][Full Text] [Related]
18. [Immune status of the spleen and surgical treatment in patients with advanced gastric cancer].
Zhu Z
Zhonghua Yi Xue Za Zhi; 1992 Jun; 72(6):330-3, 381. PubMed ID: 1332809
[TBL] [Abstract][Full Text] [Related]
19. Comparison of CD4 and CD8 lymphocyte counts in HIV-negative pulmonary TB patients with those in normal blood donors and the effect of antitubercular treatment: hospital-based flow cytometric study.
Uppal SS; Tewari SC; Verma S; Dhot PS
Cytometry B Clin Cytom; 2004 Sep; 61(1):20-6. PubMed ID: 15351978
[TBL] [Abstract][Full Text] [Related]
20. Normalized CD8+ but not CD4+ lymphocyte IL-2 expression is associated with early treatment with highly active antiretroviral therapy.
Akerele T; Galatowicz G; Bunce C; Calder V; Lynn WA; Lightman S
Clin Immunol; 2006 Nov; 121(2):191-7. PubMed ID: 16987710
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
